Ginkgo Bioworks Holdings Inc (NYSE:DNA)
| 1.77 Delayed Data As of 3:59pm ET |  -0.01 / -0.56%Today’s Change | 1.12 Today|||52-Week Range 4.91 | +4.73% Year-to-Date |
Latest DNA News | Press Releases
No recent news for Ginkgo Bioworks Holdings Inc.
Today’s Trading
| Previous close | 1.78 |
| Today’s open | 1.76 |
| Day’s range | 1.69 - 1.81 |
| Volume | 17,697,851 |
| Average volume (3 months) | 20,535,859 |
| Market cap | $3.2B |
Data as of 3:59pm ET, 06/08/2023
Growth & Valuation
| Earnings growth (last year) | -10.38% |
| Earnings growth (this year) | +74.61% |
| Earnings growth (next 5 years) | +47.59% |
| Revenue growth (last year) | +52.21% |
| P/E ratio | NM |
| Price/Sales | 5.94 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 15, 2023 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $477.7M |
| Annual profit (last year) | -$2.1B |
| Net profit margin | -440.63% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters --, -- |
Forecasts
